Is HAS-BLED score better than CHADS2 and HEMOR2RHAGES schemes in assessing 1 year risk of major bleed in atrial fibrillation patients?

Journal of the Pakistan Medical Association

Volumn 63, Issue 2, 2013, Pages 281-282

  Kamran, Syed Habibullah ^a   Muzammil, Syeda Maria ^b   Kamal, Ayeesha Kamran ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ARTICLE; BLEEDING; CHADS2 SCORE; HAS BLED SCORE; HEART ATRIUM FIBRILLATION; HEMOR2RHAGES SCORE; HUMAN; RISK ASSESSMENT; SCORING SYSTEM;

EID: 84873803812     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Pisters R, Lane DA, Nieuwalaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138: 1093-100.
2. Stroke due to atrial fibrillation in a population based stroke registry (Ludwigshafen Stroke Study) CHADS (2), CHA (2) DS (2) - VASc Score, under use oforal anticoagulation and implications for preventive measures. Eur J Neurol 2012. Jul 12. doi: 10.1111/j.1468-1331.2012.03804.x. [Epub ahead of print]
3. Apostolakis S, Lane DA, Guo Y, Buller H, Lip Gy. Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation: The AMADEUS (Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation) Study. J Am Coll Cardiol 2012; 60: 861-7. doi:10.1016/j.jacc.2012.06.019.